When poor air quality compounds infection risk

Air quality and respiratory infection are usually tracked separately — by different agencies, on different dashboards, with different audiences. The biology doesn't make that separation. PM2.5 inflames the same airway epithelium that influenza, RSV, and SARS-CoV-2 are trying to colonize, and there's a growing body of evidence that sustained PM2.5 exposure raises both incidence and severity of respiratory infection.

The airway-defense layer

The respiratory tract has a defended boundary that pathogens have to get past before they can cause an infection:

• Mucociliary clearance. A thin mucus blanket traps inhaled particles; cilia beat at ~10 Hz to sweep that blanket toward the throat where it's swallowed and inactivated.
• Innate immune sensing. Resident macrophages, dendritic cells, and alveolar epithelial cells respond to pathogen-associated molecular patterns within hours of exposure.
• Type-I interferon response. Local cells release IFN-α and IFN-β when they detect viral RNA, inducing antiviral states in neighboring cells before infection spreads.

How PM2.5 exposure undermines each layer

The published literature documents disruption of all three:

• PM2.5 disrupts mucociliary clearance. In both human and animal studies, sustained PM2.5 exposure thickens airway mucus, slows ciliary beat frequency, and reduces the mucociliary transport velocity. The first line of pathogen defense is degraded.
• PM2.5 induces local inflammation. Inflamed epithelium expresses more of the cell-surface receptors viruses use to enter cells — ACE2 for SARS-CoV-2 and other coronaviruses, sialic acid for influenza. The "front door" is more available.
• PM2.5 suppresses type-I interferon. Particulate exposure dampens IFN-α/β release in response to viral RNA. Cohort studies during the 2020 California wildfire season reported higher COVID case rates in counties under heavy smoke — adjusted for population density and timing.

The combined-exposure picture

The interaction doesn't require either input to be at "Hazardous" levels. Moderate AQI plus a high-incidence respiratory-virus wave produces meaningfully elevated risk for sensitive groups — the sensitive-groups list overlaps almost perfectly between the two domains:

• Adults 65+
• Children under 5
• People with asthma or COPD
• Pregnant people
• Immunocompromised adults (transplant, chemotherapy, biologic therapy, advanced HIV)
• People with cardiovascular disease

The same masking and indoor-air-filtration measures cover both exposures — a well-fitted N95 reduces PM2.5 dose and infectious-aerosol dose equally well; a HEPA-filter HVAC upgrade reduces both. The cost-benefit on those interventions shifts when both pressures are present at the same time.

Reading the two feeds together

The relevant data lives in two places:

• For air quality: EPA AirNow is the canonical regulatory source. Smog Report is an independent iOS app + web reader of AirNow with widgets and Live Activities; its AQI and outbreaks guide is the air-quality-side companion to this page.
• For respiratory-illness surveillance: CDC's Respiratory Virus Data Dashboard is the canonical aggregated source. Pandemic Watch surfaces the same picture in News and the Outbreaks archive, plus state-level Florida surveillance for readers in that region.

During the few weeks per year both signals are elevated, the two-axis decision is meaningfully harder than either input would suggest alone. The interventions are the same; the threshold for using them moves down.

What this page is not

This is an explainer summarizing published EPA, CDC, and peer-reviewed literature for general readers. It is not medical advice; do not use it to set personal action thresholds. Sensitive-group individuals should discuss combined-exposure decisions with a clinician. Pandemic Watch is independent and is not affiliated with EPA, CDC, or any healthcare provider.